Suppr超能文献

用于治疗动脉导管未闭的器械封堵术与开放手术封堵术的成本效益及术后结果比较。

Comparison of cost-effectiveness and postoperative outcome of device closure and open surgery closure techniques for treatment of patent ductus arteriosus.

作者信息

Ahmadi Alireza, Sabri Mohammadreza, Bigdelian Hamid, Dehghan Bahar, Gharipour Mojgan

机构信息

Assistant Professor, Isfahan Cardiovascular Research Centre, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Professor, Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

ARYA Atheroscler. 2014 Jan;10(1):37-40.

Abstract

BACKGROUND

Various devices have been recently employed for percutaneous closure of the patent ductus arteriosus (PDA). Although the high effectiveness of device closure techniques has been clearly determined, a few studies have focused on the cost-effectiveness and also postoperative complications of these procedures in comparison with open surgery. The present study aimed to evaluate the clinical outcome and cost-effectiveness of PDA occlusion by Amplatzer and coil device in comparisong with open surgery.

METHODS

In this cross-sectional study, a randomized sample of 201 patients aged 1 month to 16 years (105 patients with device closure and 96 patients with surgical closure) was selected. The ratio of total pulmonary blood flow to total systemic blood flow, the Qp/Qs ratio, was measured using a pulmonary artery catheter. The cost analysis included direct medical care costs associated with device implantation and open surgery, as well as professional fees. All costs were calculated in Iranian Rials and then converted to US dollars.

RESULTS

There was no statistical difference in mean Qp/Qs ratio before the procedure between the device closure group and the open surgery group (2.1 ± 0.7 versus 1.7 ± 0.6, P = 0.090). The mean measured costs were overall higher in the device closure group than in open closure group (948.87 ± 548.76 US$ versus 743.70 ± 696.91 US$, P < 0.001). This difference remained significant after adjustment for age and gender (Standardized Beta = 0.160, P = 0.031). PDA closure with the Amplatzer ductal occluder (1053.05 ± 525.73 US$) or with Nit-Occlud coils (PFM) (912.73 ± 565.94 US$, P < 0.001) was more expensive than that via open surgery. However, the Cook detachable spring coils device closure (605.65 ± 194.62 US$, P = 0.650) had a non-significant cost difference with open surgery. No event was observed in the device closure group regarding in-hospital mortality or morbidity; however, in another group, 2 in-hospital deaths occurred, two patients experienced pneumonia and seizure, and one suffered electrolyte abnormalities including hyponatremia and hypocalcemia.

CONCLUSION

Although open surgery seems to be less expensive than device closure technique, because of lower mortality and morbidity, the latter group is more preferable.

摘要

背景

近年来,各种装置已被用于经皮闭合动脉导管未闭(PDA)。尽管装置闭合技术的高效性已得到明确证实,但与开放手术相比,很少有研究关注这些手术的成本效益以及术后并发症。本研究旨在评估使用Amplatzer和弹簧圈装置闭合PDA与开放手术相比的临床结局和成本效益。

方法

在这项横断面研究中,选取了201例年龄在1个月至16岁之间的随机样本患者(105例行装置闭合,96例行手术闭合)。使用肺动脉导管测量肺总血流量与体循环总血流量之比,即Qp/Qs比值。成本分析包括与装置植入和开放手术相关的直接医疗费用以及专业费用。所有成本均以伊朗里亚尔计算,然后换算成美元。

结果

装置闭合组和开放手术组术前平均Qp/Qs比值无统计学差异(2.1±0.7对1.7±0.6,P = 0.090)。装置闭合组的平均测量成本总体高于开放闭合组(948.87±548.76美元对743.70±696.91美元,P < 0.001)。在对年龄和性别进行调整后,这种差异仍然显著(标准化β = 0.160,P = 0.031)。使用Amplatzer导管封堵器(1053.05±525.73美元)或Nit-Occlud弹簧圈(PFM)(912.73±565.94美元,P < 0.001)闭合PDA比开放手术更昂贵。然而,使用Cook可脱卸弹簧圈装置闭合(605.65±194.62美元,P = 0.650)与开放手术的成本差异无统计学意义。装置闭合组未观察到院内死亡或发病事件;然而,在另一组中,发生了2例院内死亡,2例患者出现肺炎和癫痫发作,1例患者出现包括低钠血症和低钙血症在内的电解质异常。

结论

尽管开放手术似乎比装置闭合技术成本更低,但由于死亡率和发病率较低,后者更可取。

相似文献

7
Immediate angiographic residual shunt using the Nit-Occlud device for patent ductus arteriosus closure.
Postepy Kardiol Interwencyjnej. 2020 Dec;16(4):460-465. doi: 10.5114/aic.2020.101772. Epub 2020 Dec 29.
8
Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less.
Korean J Pediatr. 2010 Dec;53(12):1012-7. doi: 10.3345/kjp.2010.53.12.1012. Epub 2010 Dec 31.

引用本文的文献

本文引用的文献

2
Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions.
Circulation. 2008 Feb 26;117(8):1090-9. doi: 10.1161/CIRCULATIONAHA.107.714402.
3
Patent ductus arteriosus.
Circulation. 2006 Oct 24;114(17):1873-82. doi: 10.1161/CIRCULATIONAHA.105.592063.
5
Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results.
J Am Coll Cardiol. 2004 Aug 4;44(3):513-9. doi: 10.1016/j.jacc.2004.03.074.
6
The Amplatzer duct occluder: experience in 209 patients.
J Am Coll Cardiol. 2001 Jan;37(1):258-61. doi: 10.1016/s0735-1097(00)01094-9.
7
Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial.
Catheter Cardiovasc Interv. 2000 Sep;51(1):50-4. doi: 10.1002/1522-726x(200009)51:1<50::aid-ccd11>3.0.co;2-6.
8
Aortic obstruction caused by device occlusion of patent arterial duct.
Heart. 1999 Jul;82(1):109-11. doi: 10.1136/hrt.82.1.109.
10
Video-thoracoscopic surgical interruption of patent ductus arteriosus. Routine experience in 332 pediatric cases.
Eur J Cardiothorac Surg. 1997 Jun;11(6):1052-5. doi: 10.1016/s1010-7940(97)00093-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验